People · Operator

NICHOLAS N. KEEN

Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals

1
Companies
1
Filings
$555.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bicycle Therapeutics PlcPharmaceuticalsGrowth/Late$555.5M$7.3B2024
Operator network

NICHOLAS N. KEEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kevin Lee · 6 companies · 1 sharedKevin LeeFELIX J. BAKER · 4 companies · 1 sharedFELIX J. BAKERPIERRE LEGAULT · 2 companies · 1 sharedPIERRE LEGAULTALETHIA YOUNG · 1 companies · 1 sharedALETHIA YOUNGALISTAIR N. MILNES · 1 companies · 1 sharedALISTAIR N. MILNESGREGORY N. WINTER · 1 companies · 1 sharedGREGORY N. WINTERJANICE J. BOURQUE · 1 companies · 1 sharedJANICE J. BOURQUEJOSE-CARLOS J. GUTIERREZ-RAMOS · 1 companies · 1 sharedJOSE-CARLOS J. GU…MICHAEL N. HANNAY · 1 companies · 1 sharedMICHAEL N. HANNAYMICHAEL N. SKYNNER · 1 companies · 1 sharedMICHAEL N. SKYNNERNIGEL N. CROCKETT · 1 companies · 1 sharedNIGEL N. CROCKETTRICHARD N. KENDER · 1 companies · 1 sharedRICHARD N. KENDERSANTIAGO N. ARROYO · 1 companies · 1 sharedSANTIAGO N. ARROYOSTEPHEN N. SANDS · 1 companies · 1 sharedSTEPHEN N. SANDSBicycle Therapeutics Plc · $555.5M raisedBicycle Therapeutics …NICHOLAS N. KEENNK
NICHOLAS N. KEEN Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside NICHOLAS N. KEEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kevin Lee16
FELIX J. BAKER14
PIERRE LEGAULT12
STEPHEN N. SANDS11
NIGEL N. CROCKETT11
JOSE-CARLOS J. GUTIERREZ-RAMOS11
SANTIAGO N. ARROYO11
MICHAEL N. HANNAY11
MICHAEL N. SKYNNER11
ALISTAIR N. MILNES11
ALETHIA YOUNG11
JANICE J. BOURQUE11
RICHARD N. KENDER11
GREGORY N. WINTER11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.